跳转至内容

关于应对近期政策变化的重要更新,请点击此处查看详情。

Merck
CN

14380C

SAFC

EX-CELL® CD昆虫细胞培养基

Chemically defined, sterile-filtered, suitable (for insect cell culture)

制药生产

登录查看公司和协议定价

选择尺寸

1 EA
¥15,802.30

¥15,802.30


请联系客服了解存货情况


选择尺寸

变更视图
1 EA
¥15,802.30

About This Item

UNSPSC代码:
12352207

¥15,802.30


请联系客服了解存货情况

质量水平

无菌性

sterile-filtered

产品线

EX-CELL®

表单

liquid

技术

cell culture | insect: suitable

组分

NaHCO3: no
L-glutamine: yes

运输

ambient

储存温度

2-8°C

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
GF38122893GF80164964GF15199331
铂 foil, not light tested, 100x100mm, thickness 0.01mm, as rolled, 99.95%

GF95421450

铂 foil, not light tested, 100x100mm, thickness 0.004mm, as rolled, 99.95%

GF38122893

铂 foil, not light tested, 100x100mm, thickness 0.005mm, as rolled, 99.95%

GF80164964

铂 foil, not light tested, 100x100mm, thickness 0.002mm, as rolled, 99.95%

GF15199331

manufacturer/tradename

Goodfellow 954-214-50

manufacturer/tradename

Goodfellow 381-228-93

manufacturer/tradename

Goodfellow 801-649-64

manufacturer/tradename

Goodfellow 151-993-31

form

foil

form

foil

form

foil

form

foil

bp

3827 °C (lit.)

bp

3827 °C (lit.)

bp

3827 °C (lit.)

bp

3827 °C (lit.)

resistivity

10.6 μΩ-cm, 20°C

resistivity

10.6 μΩ-cm, 20°C

resistivity

10.6 μΩ-cm, 20°C

resistivity

10.6 μΩ-cm, 20°C

mp

1772 °C (lit.)

mp

1772 °C (lit.)

mp

1772 °C (lit.)

mp

1772 °C (lit.)

一般描述

EX-CELL® CD昆虫细胞培养基可作为草地夜蛾(Spodoptera frugiperda, Sf)细胞(例如Sf21和Sf9细胞)的扩增和生产培养基,也适合Tni、C636和S2细胞。该培养基优化用于无弹状病毒的Sf-RVN昆虫细胞株(Sf9)的优异生长和生产,两者共同组成Sf-RVN平台。培养基配方化学成分明确、不含动物成分,含有L-谷氨酰胺。

法律信息

EX-CELL is a registered trademark of Merck KGaA, Darmstadt, Germany
Sf-RVN is a trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

12 - Non Combustible Liquids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

常规特殊物品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Minimize the complexities of cell and gene therapy production. Switch to upstream viral vector platforms to enhance scalability and simplify GMP manufacturing.

Upstream gene therapy optimization maximizes viral vector titers; partner with technology experts for HEK293, HEK293T, and Sf9 cell solutions.

This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.

相关内容

针对病毒载体生产的转染解决方案采用悬浮细胞系、化学成分明确的培养基以及性能已得到证明的工艺。

A transfection-based solution to viral vector production using a suspension cell line, chemically defined medium, and a process with proven performance at scale.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持